ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

NCI Awards Grants To Physicians For Cancer Detection

August 2, 1991

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007

Non-Chemo Agents Added To Regimens For Lymphomas

January 26, 2007

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

How to Become a Urology Millionaire…Alas, One Little Problem—Overtreatment

April 13, 2012

Panel Unenthused About New Toxicity Testing Program

December 15, 1978